Technical Analysis for FLGT - Fulgent Genetics, Inc.

Grade Last Price % Change Price Change
grade B 5.55 -4.80% -0.28
FLGT closed down 4.8 percent on Monday, March 18, 2019, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical FLGT trend table...

Date Alert Name Type % Chg
Mar 18 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 18 NR7 Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Overbought Stochastic Strength 0.00%
Mar 15 1,2,3 Pullback Bullish Bullish Swing Setup -4.80%
Mar 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.80%
Mar 15 Upper Bollinger Band Walk Strength -4.80%
Mar 15 Wide Bands Range Expansion -4.80%
Mar 15 Overbought Stochastic Strength -4.80%

Older signals for FLGT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Medicine Technology Biotechnology Cancers Genetics Medical Genetics Medical Tests Cardiovascular Diseases Neurological Disorders Molecular Diagnostics Applied Genetics Genetic Testing Qiagen Alternatives To Animal Testing
Is FLGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.1207
52 Week Low 3.02
Average Volume 20,901
200-Day Moving Average 4.0494
50-Day Moving Average 4.4308
20-Day Moving Average 5.014
10-Day Moving Average 5.455
Average True Range 0.3735
ADX 34.94
+DI 29.3357
-DI 14.7166
Chandelier Exit (Long, 3 ATRs ) 5.0002
Chandelier Exit (Short, 3 ATRs ) 5.2805
Upper Bollinger Band 6.1555
Lower Bollinger Band 3.8725
Percent B (%b) 0.73
BandWidth 45.532509
MACD Line 0.4263
MACD Signal Line 0.364
MACD Histogram 0.0623
Fundamentals Value
Market Cap 98.46 Million
Num Shares 17.7 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -7.40
Price-to-Sales 3.32
Price-to-Book 1.24
PEG Ratio 0.85
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.00
Resistance 3 (R3) 6.05 5.95 5.93
Resistance 2 (R2) 5.95 5.84 5.93 5.90
Resistance 1 (R1) 5.75 5.76 5.70 5.70 5.87
Pivot Point 5.65 5.65 5.63 5.63 5.65
Support 1 (S1) 5.45 5.54 5.40 5.40 5.23
Support 2 (S2) 5.35 5.46 5.33 5.20
Support 3 (S3) 5.15 5.35 5.18
Support 4 (S4) 5.10